TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma (Prolong)

Condition:   Carcinoma, Hepatocellular Interventions:   Drug: Lenvatinib;   Procedure: TACE Sponsor:   Zhejiang Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials